Advanced search
Publication Cover
Modern Rheumatology Volume 17, 2007 - Issue 5
Journal homepage
48
Views
26
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Elevation of serum matrix metalloproteinase-3 as a predictive marker for the long-term disability of rheumatoid arthritis patients in a prospective observational cohort IORRA

Mikiko ShinozakiInstitute of Rheumatology, Tokyo Women's Medical University,10-22 Kawada-cho, Shinjuku-ku, Tokyo 162-0054, JapanCorrespondence[email protected]
,
Eisuke InoueInstitute of Rheumatology, Tokyo Women's Medical University,10-22 Kawada-cho, Shinjuku-ku, Tokyo 162-0054, Japan
,
Ayako NakajimaInstitute of Rheumatology, Tokyo Women's Medical University,10-22 Kawada-cho, Shinjuku-ku, Tokyo 162-0054, Japan
,
Masako HaraInstitute of Rheumatology, Tokyo Women's Medical University,10-22 Kawada-cho, Shinjuku-ku, Tokyo 162-0054, Japan
,
Taisuke TomatsuInstitute of Rheumatology, Tokyo Women's Medical University,10-22 Kawada-cho, Shinjuku-ku, Tokyo 162-0054, Japan
,
Naoyuki KamataniInstitute of Rheumatology, Tokyo Women's Medical University,10-22 Kawada-cho, Shinjuku-ku, Tokyo 162-0054, Japan
&
Hisashi YamanakaInstitute of Rheumatology, Tokyo Women's Medical University,10-22 Kawada-cho, Shinjuku-ku, Tokyo 162-0054, Japan
 show all
Pages 403-408 | Received 30 Jan 2007, Accepted 01 Jun 2007, Published online: 02 Jan 2014

References

  • Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breedveld FC, Kalden JR, et al. Infl iximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 2000;343:1594–602.
  • Genovese MC, Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH. Etanercept versus methotrexate in patients with early rheumatoid arthritis. Arthritis Rheum 2002;46:1443–50.
  • van der Heijde DM, van't Hof M, van Riel PL, Theunisse LAM, Lubberts EW, van Leeuwen MA, et al. Judging disease activity in clinical practice in rheumatoid arthritis: fi rst step in the development of disease activity score. Ann Rheum Dis 1990;49:916–20.
  • Prevoo MLL, van't Hof MA, Kuper HH, van Leeuwen MA, van de Puute LBA, van Riel PL. Modifi ed disease activity scores that include 28 joint counts. Arthritis Rheum 1995;38: 44–8.
  • Smolen JS, Breedveld FC, Schiff MH, Kalden JR, Emery P, Eberl G, et al. A simplifi ed disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford) 2003;42: 244–57.
  • Aletaha D, Nell VP, Stamm T, Uffmann M, Pfl ugbeli S, Machold K, et al. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther 2005;7:796–806.
  • Momohara S, Yamanaka H, Holledge MM, Mizumura T, Ikari K, Okada N, et al. Cartilage oligomeric matrix protein in serum and synovial fl uid of rheumatoid arthritis: potential use as a marker for joint cartilage damage. Mod Rheumatol 2004;14:356–60.
  • Ribbens C, Andre B, Jaspar JM, Kaye O, Kaiser MJ, De Groote D, et al. Matrix metalloproteinase-3 serum levels are correlated with disease activity and predict clinical response in rheumatoid arthritis. J Rheumatol 2000;27: 888–93.
  • Matsuda Y, Singh G, Yamanaka H, Tanaka E, Urano W, Taniguchi A, et al. Validation of a Japanese version of the Stanford health assessment questionnaire in 3763 patients with rheumatoid arthritis. Arthritis Rheum 2003;49(6):784–8.
  • Yamanaka H, Matsuda Y, Tanaka M, Sendo W, Nakajima H, Taniguchi A, et al. Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement, in patients with early rheumatoid arthritis. Arthritis Rheum 2000;43:852–8.
  • Green MJ, Gough AK, Devlin J, Smith J, Astin P, Taylor D. Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis. Rheumatology (Oxford) 2003;42(1):83–8.
  • Peake NJ, Khawaja K, Myers A, Jones D, Cawston TE, Rowan AD, et al. Levels of matrix metalloproteinase (MMP)-1 in paired sera and synovial fl uids of juvenile idiopathic arthritis patients: relationship to infl ammatory activity, MMP-3 and tissue inhibitor of metalloproteinases-1 in a longitudinal study. Rheumatology (Oxford) 2005;44:1383–9.
  • Drossaers-Bakker KW, Zwinderman AH, Vlieland TP, Van Zeben D, Vos K, Breedveld FC, et al. Long-term outcome in rheumatoid arthritis: a simple algorithm of baseline parameters can predict radiographic damage, disability, and disease course at 12-year followup. Arthritis Rheum 2002;47: 383–90.
  • Helen T. Dennis AC. Rheumatoid factor. In: Kelley WN, Harris ED Jr, Ruddy S, Sledge CB, editors. Textbooks of rheumatology. 6th ed. Philadelphia: WB Saunders; 2001. p. 151–60.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.